Summary
Michael Bell is a seasoned medicinal chemistry leader with over 30 years driving preclinical drug discovery and delivering hit-to-clinic molecules across autoimmune, cardiovascular, metabolic, and renal disease areas. Currently Senior Director at Eli Lilly, he has progressed through technical and leadership roles since 1994, combining hands-on synthetic route design with multi-variate SAR/SPR strategies. He co-invents on 20 composition-of-matter patents and numerous publications, reflecting a sustained record of tangible innovation. Michael’s strengths include external innovation partnerships, international collaboration, and translating in silico insights into practical medchem decisions. He also brings uncommon product-minded experience for a chemist—having designed medchem data management user interfaces and applied Six Sigma principles to discovery workflows. Based in Indianapolis, he blends deep domain expertise with a pragmatic focus on enabling teams to deliver clinical candidates.
8 years of coding experience
28 years of employment as a software developer
Graduate Non-degree, Organic Chemistry, Graduate Non-degree, Organic Chemistry at Indiana University–Purdue University Indianapolis
BS, Chemistry, BS, Chemistry at University of Notre Dame